Skip to main content
. 2020 May 14;10(2):2045894020919355. doi: 10.1177/2045894020919355

Fig. 4.

Fig. 4.

Summary of the present study. Proposed mechanisms of pharmacomodulation of BM-derived cells by bosentan are shown with the present findings.

BM: bone marrow; EC: endothelial cell; MCP1: monocyte chemoattractant protein-1; IL6: interleukin 6; SDF1: stromal cell-derived factor.